Arrighi, I; Mark, S; Alvisi, M; von Rechenberg, B; Hubbell, J A; Schense, J C (2009). Bone healing induced by local delivery of an engineered parathyroid hormone prodrug. Biomaterials, 30(9):1763-1771.
Wechsler, S; Fehr, D; Molenberg, A; Raeber, G; Schense, J C; Weber, Franz E (2008). A novel, tissue occlusive poly(ethylene glycol) hydrogel material. Journal of Biomedical Materials Research Part A, 85A(2):285-292.
Schmoekel, H G; Weber, Franz E; Schense, J C; Grätz, K W; Schawalder, P; Hubbell, J A (2005). Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnology and Bioengineering, 89(3):253-262.
Schmoekel, H G; Weber, Franz E; Hurter, K; Schense, J C; Seiler, G; Ryrz, U; Spreng, D; Schawalder, P; Hubbell, J (2005). Enhancement of bone healing using non-glycosylated rhBMP-2 released from a fibrin matrix in dogs and cats. Journal of Small Animal Practice, 46(1):17-21.
Schmoekel, H; Schense, J C; Weber, Franz E; Grätz, K W; Gnägi, D; Müller, R; Hubbell, J A (2004). Bone healing in the rat and dog with nonglycosylated BMP-2 demonstrating low solubility in fibrin matrices. Journal of Orthopaedic Research, 22(2):376-381.
Schmökel, H G; Weber, Franz E; Seiler, G; von Rechenberg, B; Schense, J C; Schawalder, P; Hubbell, J (2004). Treatment of nonunions with nonglycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix. Veterinary Surgery, 33(2):112-118.